TVRD
Tvardi Therapeutics
TVRD
TVRD
67 hedge funds and large institutions have $12.1M invested in Tvardi Therapeutics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
88% less capital invested
Capital invested by funds: $102M → $12.1M (-$90.1M)
Holders
67
Holding in Top 10
–
Calls
$95K
Puts
–
Top Buyers
| 1 | +$2M | |
| 2 | +$723K | |
| 3 | +$705K | |
| 4 |
Renaissance Technologies
New York
|
+$666K |
| 5 |
BlackRock
New York
|
+$547K |
Top Sellers
| 1 | -$6.77M | |
| 2 | -$6.51M | |
| 3 | -$3.22M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.53M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$787K |
